FDA authorizes change in how monkeypox vaccine is administered, boosting supply amid high demand
The vaccine can now be given to high-risk adults intradermally, that is, between the layers of the skin, instead of subcutaneously, or under the skin, as has been given up until now. This will allow providers to obtain five doses from a standard one-dose vial. The new US also allows subcutaneous vaccination in people under …